COMPANY
CIPLA (EU) LIMITED
CIPLA (EU) LIMITED: marketing authorisation holder for Daptomycin, Icatibant, Liraglutide, Teduglutide, Teriparatide, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Daptomycin | DAPTOMYCIN 350 MG POWDER FOR SOLUTION FOR INJECTION OR INFUSION, PLGB 36390/0374, Authorised Regulator MHRA |
|---|---|
| Daptomycin | DAPTOMYCIN 500 MG POWDER FOR SOLUTION FOR INJECTION OR INFUSION, PLGB 36390/0375, Authorised Regulator MHRA |
| Icatibant | ICATIBANT 30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PLGB 36390/0285, Authorised Regulator MHRA |
| Liraglutide | PINSUBET 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN, PL 36390/0416, Authorised Regulator MHRA |
| Liraglutide | PLAOBES 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN, PL 36390/0417, Authorised Regulator MHRA |
| Teduglutide | TEDUGLUTIDE CIPLA 5 MG/VIAL POWDER AND SOLVENT FOR SOLUTION FOR INJECTION, PL 36390/0454, Authorised Regulator MHRA |
| Teriparatide | TERIPARATIDE CIPLA 20 MICROGRAMS/80 MICROLITRES SOLUTION FOR INJECTION IN PRE-FILLED PEN, PL 36390/0394, Authorised Regulator MHRA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.